Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Hypothesis: Could Hepatitis B vaccine act as an immune adjuvant in glioblastoma? Clues to conduct further epidemiological analyses.

Altinoz MA, Ozpinar A, Ozpinar A, Hacker E, Elmaci İ.

Int Immunopharmacol. 2019 Nov 19:106038. doi: 10.1016/j.intimp.2019.106038. [Epub ahead of print] Review.

PMID:
31757678
2.

Could hepatitis B vaccine act as an adjuvant to lower risk and relapses of cancer?

Altinoz MA, Ozpinar A, Ozpinar A, Hacker E, Elmaci İ.

Clin Exp Pharmacol Physiol. 2019 Aug;46(8):694-704. doi: 10.1111/1440-1681.13096. Epub 2019 May 7. Review.

PMID:
31002181
3.

Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.

Huynh C, Minuk GY, Uhanova J, Baikie M, Wong T, Osiowy C.

Vaccine. 2017 Aug 16;35(35 Pt B):4515-4522. doi: 10.1016/j.vaccine.2017.07.040. Epub 2017 Jul 21.

PMID:
28736196
4.

Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.

Wang X, Dong A, Xiao J, Zhou X, Mi H, Xu H, Zhang J, Wang B.

Cell Mol Immunol. 2016 Nov;13(6):850-861. doi: 10.1038/cmi.2015.64. Epub 2015 Jul 13.

5.

Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).

Azarkeivan A, Karimi G, Shaiegan M, Maghsudlu M, Tabbaroki A.

Pediatr Hematol Oncol. 2009 Jun;26(4):195-201. doi: 10.1080/08880010902895900.

PMID:
19437322
6.

Prevention of perinatal transmission of hepatitis B virus (HBV) to children of e antigen-positive HBV carrier mothers by hepatitis B immune globulin and HBV vaccine.

Kanai K, Takehiro A, Noto H, Nishida M, Takahashi K, Kawashima Y, Igarashi Y, Matsushita K, Shimizu M.

J Infect Dis. 1985 Feb;151(2):287-90.

PMID:
3155779
7.

Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.

Whittle HC, Maine N, Pilkington J, Mendy M, Fortuin M, Bunn J, Allison L, Howard C, Hall A.

Lancet. 1995 Apr 29;345(8957):1089-92.

PMID:
7715343
8.

A novel hepatitis B virus species discovered in capuchin monkeys sheds new light on the evolution of primate hepadnaviruses.

de Carvalho Dominguez Souza BF, König A, Rasche A, de Oliveira Carneiro I, Stephan N, Corman VM, Roppert PL, Goldmann N, Kepper R, Müller SF, Völker C, de Souza AJS, Gomes-Gouvêa MS, Moreira-Soto A, Stöcker A, Nassal M, Franke CR, Rebello Pinho JR, Soares MDCP, Geyer J, Lemey P, Drosten C, Netto EM, Glebe D, Drexler JF.

J Hepatol. 2018 Jun;68(6):1114-1122. doi: 10.1016/j.jhep.2018.01.029. Epub 2018 Feb 8.

9.

China's efforts to shed its title of "Leader in liver disease".

Li X, Xu WF.

Drug Discov Ther. 2007 Oct;1(2):84-5.

10.

Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice.

Bian Y, Zhang Z, Sun Z, Zhao J, Zhu D, Wang Y, Fu S, Guo J, Liu L, Su L, Wang FS, Fu YX, Peng H.

Hepatology. 2017 Oct;66(4):1067-1082. doi: 10.1002/hep.29239. Epub 2017 Aug 26.

11.

Host genetic factors affecting hepatitis B infection outcomes: Insights from genome-wide association studies.

Akcay IM, Katrinli S, Ozdil K, Doganay GD, Doganay L.

World J Gastroenterol. 2018 Aug 14;24(30):3347-3360. doi: 10.3748/wjg.v24.i30.3347. Review.

12.

Development of a more efficient hepatitis B virus vaccine by targeting hepatitis B virus preS to dendritic cells.

Jing M, Wang J, Zhu S, Ao F, Wang L, Han T, Yue X, Zhu Y, Ye L, Liu S.

Vaccine. 2016 Jan 20;34(4):516-522. doi: 10.1016/j.vaccine.2015.11.069. Epub 2015 Dec 12.

PMID:
26686999
13.

A Highly Attenuated Vesicular Stomatitis Virus-Based Vaccine Platform Controls Hepatitis B Virus Replication in Mouse Models of Hepatitis B.

Moshkani S, Chiale C, Lang SM, Rose JK, Robek MD.

J Virol. 2019 Feb 19;93(5). pii: e01586-18. doi: 10.1128/JVI.01586-18. Print 2019 Mar 1.

14.

Glioblastoma multiforme and hepatitis B: do the right thing(s).

Purchiaroni F, Begini P, Minniti G, Gallina S, Delle Fave G, Marignani M.

Eur Rev Med Pharmacol Sci. 2014;18(23):3629-31.

15.

Poly(I:C)/alum mixed adjuvant priming enhances HBV subunit vaccine-induced immunity in mice when combined with recombinant adenoviral-based HBV vaccine boosting.

Chuai X, Chen H, Wang W, Deng Y, Wen B, Ruan L, Tan W.

PLoS One. 2013;8(1):e54126. doi: 10.1371/journal.pone.0054126. Epub 2013 Jan 15.

16.

Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.

Conti S, Vexler A, Edry-Botzer L, Kalich-Philosoph L, Corn BW, Shtraus N, Meir Y, Hagoel L, Shtabsky A, Marmor S, Earon G, Lev-Ari S.

PLoS One. 2018 Jul 3;13(7):e0198627. doi: 10.1371/journal.pone.0198627. eCollection 2018.

17.

Meta-analysis: levamisole improves the immune response to hepatitis B vaccine in dialysis patients.

Fabrizi F, Dixit V, Messa P, Martin P.

Aliment Pharmacol Ther. 2010 Sep;32(6):756-62. doi: 10.1111/j.1365-2036.2010.04410.x. Epub 2010 Jul 20.

18.
19.

Use of pre-S protein-containing hepatitis B virus surface antigens and a powerful adjuvant to develop an immune therapy for chronic hepatitis B virus infection.

Yum JS, Ahn BC, Jo HJ, Kim DY, Kim KH, Kim HS, Sung YC, Yoon J, Morrey J, Moon HM.

Clin Vaccine Immunol. 2012 Feb;19(2):120-7. doi: 10.1128/CVI.05355-11. Epub 2011 Dec 7.

20.

Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.

Moses J, Alkhouri N, Shannon A, Raig K, Lopez R, Danziger-Isakov L, Feldstein AE, Zein NN, Wyllie R, Carter-Kent C.

Am J Gastroenterol. 2012 Jan;107(1):133-8. doi: 10.1038/ajg.2011.295. Epub 2011 Aug 30.

PMID:
21876562

Supplemental Content

Support Center